2025 Japan Biopreservation Market Revenue Opportunities Report
Description
The 2025 Japan Biopreservation Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Biopreservation Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the biopreservation market in Japan include PHC Holdings Corporation (Japan), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), and Azenta, Inc. (US). PHC Holdings Corporation, headquartered in Japan, is a key player with a strong regional presence and diversified technologies focused on biopreservation equipment and media. Thermo Fisher Scientific holds a global leadership position backed by a broad portfolio of ultra-low temperature freezers, cryopreservation media, and integrated biobanking solutions widely adopted in Japan and worldwide. Merck KGaA is known for its innovative product range in biopreservation media and equipment, supporting research and therapeutic applications. Azenta, Inc. provides specialized biopreservation services and products critical to Japan’s expanding regenerative medicine and biobanking sectors.
These companies drive the Japanese biopreservation market influenced by rising healthcare expenditures, advances in regenerative medicine, and increasing organ transplantation activities. Thermo Fisher continuously upgrades its technologies, recently launching enhanced ultra-low temperature freezers to improve energy efficiency. PHC Holdings leverages its local expertise and strong distribution channels to serve research institutions and hospitals. Merck KGaA’s consistent R&D investments and product breadth contribute to its competitive edge. Azenta focuses on integrating storage and logistics to meet Japan’s demand for precise and reliable biological sample preservation. Together, they shape Japan's biopreservation landscape through sustained innovation and market expansion.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Biopreservation Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the biopreservation market in Japan include PHC Holdings Corporation (Japan), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), and Azenta, Inc. (US). PHC Holdings Corporation, headquartered in Japan, is a key player with a strong regional presence and diversified technologies focused on biopreservation equipment and media. Thermo Fisher Scientific holds a global leadership position backed by a broad portfolio of ultra-low temperature freezers, cryopreservation media, and integrated biobanking solutions widely adopted in Japan and worldwide. Merck KGaA is known for its innovative product range in biopreservation media and equipment, supporting research and therapeutic applications. Azenta, Inc. provides specialized biopreservation services and products critical to Japan’s expanding regenerative medicine and biobanking sectors.
These companies drive the Japanese biopreservation market influenced by rising healthcare expenditures, advances in regenerative medicine, and increasing organ transplantation activities. Thermo Fisher continuously upgrades its technologies, recently launching enhanced ultra-low temperature freezers to improve energy efficiency. PHC Holdings leverages its local expertise and strong distribution channels to serve research institutions and hospitals. Merck KGaA’s consistent R&D investments and product breadth contribute to its competitive edge. Azenta focuses on integrating storage and logistics to meet Japan’s demand for precise and reliable biological sample preservation. Together, they shape Japan's biopreservation landscape through sustained innovation and market expansion.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
